WO2007075388A3 - Methods of locally treating and preventing cardiac disorders - Google Patents

Methods of locally treating and preventing cardiac disorders Download PDF

Info

Publication number
WO2007075388A3
WO2007075388A3 PCT/US2006/047862 US2006047862W WO2007075388A3 WO 2007075388 A3 WO2007075388 A3 WO 2007075388A3 US 2006047862 W US2006047862 W US 2006047862W WO 2007075388 A3 WO2007075388 A3 WO 2007075388A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
cardiac disorders
preventing cardiac
locally treating
locally
Prior art date
Application number
PCT/US2006/047862
Other languages
French (fr)
Other versions
WO2007075388A2 (en
Inventor
William R Baumbach
Hariharan Shankar
Oded Ben-Joseph
Original Assignee
Cell Medical Inc X
William R Baumbach
Hariharan Shankar
Oded Ben-Joseph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Medical Inc X, William R Baumbach, Hariharan Shankar, Oded Ben-Joseph filed Critical Cell Medical Inc X
Publication of WO2007075388A2 publication Critical patent/WO2007075388A2/en
Publication of WO2007075388A3 publication Critical patent/WO2007075388A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

Abstract

The present disclosure provides methods and compositions for treating coronary tissue damaged as a result of a cardiac disorder such as ischemia, acute myocardial infarction, vulnerable plaques, or reperfusion injury. Specifically, the cardiac disorder is treated using a locally-delivered therapeutic molecule.
PCT/US2006/047862 2005-12-15 2006-12-15 Methods of locally treating and preventing cardiac disorders WO2007075388A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75074505P 2005-12-15 2005-12-15
US60/750,745 2005-12-15

Publications (2)

Publication Number Publication Date
WO2007075388A2 WO2007075388A2 (en) 2007-07-05
WO2007075388A3 true WO2007075388A3 (en) 2008-11-06

Family

ID=38218442

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/047862 WO2007075388A2 (en) 2005-12-15 2006-12-15 Methods of locally treating and preventing cardiac disorders

Country Status (1)

Country Link
WO (1) WO2007075388A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7878978B2 (en) 2004-03-18 2011-02-01 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
ES2386231T3 (en) 2007-11-30 2012-08-14 Universiteit Maastricht Diagnostic and therapeutic tool for diseases that alter vascular function
AU2010206543A1 (en) * 2009-01-26 2011-07-07 Intermune, Inc. Methods for treating acute myocardial infarctions and associated disorders
BR112017022535A2 (en) 2015-04-21 2018-07-10 Univ North Carolina State glucose responsive insulin delivery system using hypoxia sensitive nanocomposites.
CN110167537A (en) 2016-11-07 2019-08-23 北卡罗来纳州立大学 For enhancing the patch equipped with sensitive vesica of the delivering of glucose reactivity insulin

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128225A1 (en) * 2000-10-18 2002-09-12 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US20050025752A1 (en) * 2000-03-15 2005-02-03 Kutryk Michael J. B. Medical device with coating for capturing genetically-altered cells and methods for using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050025752A1 (en) * 2000-03-15 2005-02-03 Kutryk Michael J. B. Medical device with coating for capturing genetically-altered cells and methods for using same
US20020128225A1 (en) * 2000-10-18 2002-09-12 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides

Also Published As

Publication number Publication date
WO2007075388A2 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
WO2007028053A3 (en) Methods of treating and preventing cardiac disorders
HK1166465A1 (en) 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position as parp inhibitors for use in treating cancer
WO2008151288A3 (en) Aromatic and heteroaromatic compounds useful in treating iron disorders
WO2006135915A3 (en) Methods and compositions for treating degenerative bone disorders
WO2006068905A3 (en) Rapamycin derivatives and the uses thereof in the treatment of neurological disorders
MX2007005590A (en) Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof.
ATE521608T1 (en) GLUCOKINASE ACTIVATORS
WO2006052718A3 (en) Farnesyltransferase inhibitors for treating sepsis
WO2007059230A3 (en) Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
WO2006015159A3 (en) Potassium channel inhibitors
TW200740804A (en) Glucokinase activators
WO2007074406A3 (en) Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative
WO2008118718A3 (en) 2-aminopyridine analogs as glucokinase activators
WO2006138511A3 (en) Use of hif 1alfa modulators for treatment of cancer
WO2005030791A3 (en) Isoquinolinone potassium channel inhibitors
WO2006133426A3 (en) Compositions and methods for inhibition of the jak pathway
WO2005004808A3 (en) TETRACYCLIC COMPOUNDS AS c-MET INHIBITORS
SG170775A1 (en) 2 -aminopyridine analogs as glucokinase activators
WO2008034039A3 (en) Novel tetrahydro-isoquinolines
WO2008128038A3 (en) Methods and compositions for treating cardiac dysfunctions
WO2008115999A8 (en) Biaryl and biheteroaryl compounds useful in treating iron disorders
WO2005046578A3 (en) Isoquinolinone potassium channel inhibitors
WO2006113483A3 (en) Methods and compositions for treating or preventing cancer
WO2007050348A3 (en) Potassium channel inhibitors
WO2007075388A3 (en) Methods of locally treating and preventing cardiac disorders

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06847669

Country of ref document: EP

Kind code of ref document: A2